ELEmmanuel Lapitan

Emmanuel Lapitan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Emmanuel Lapitan has a total of 38 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Use of physical activity skills in daily life during a physical activity intervention for women in midlife with elevated risk for cardiovascular disease

    by Gabrielle M. Salvatore, Iris Bercovitz, Angelica R. Rivera, Giada Benasi, Emmanuel Lapitan, Amanda L. Folk, Kyle R. Haggerty, Jacqueline A. Mogle, Danielle Arigo

    Women in midlife (ages 40–65) often fail to engage in cardioprotective levels of physical activity (PA). Although behavioral PA interventions are tailored for this population, the extent to which women use the skills introduced by these interventions in daily life is unclear. In the present single-arm trial, 62 women in midlife with ≥ 1 CVD risk factors (e.g., hypertension; MAge = 52, MBMI = 31 kg/m2, 40% racial/ethnic minority identification) engaged in an 8-week PA program that taught 9 distinct behavioral, cognitive, and acceptance-based PA skills. Participants wore a PA monitor each day to capture their steps per day and daily skill use was assessed with an end-of-day survey; survey compliance was high (84%), and participants reported using an average of 2.2 skills per day. Within-person, use of an additional skill per day corresponded to 550 more steps per day (p < 0.001). Use of some PA skills changed over time and the number of skills used was slightly lower on days with intervention sessions than days without (F[1,61] = 3.99, p = 0.05). End-of-treatment ratings showed that reporting on skill use each day was highly acceptable (M = 4/5). Findings show that participants can report on their use of PA skills between sessions and use of these skills in daily life is associated with the intended behavior change and subjective experience. Additional examination of associations between daily skill use and behavior change will enable improvements to intervention programs, to better engage or remove lesser-used skills as appropriate.

  • Self-Regulation Via Visual Fixation: Effects of Strategic Shifting of Attentional Scope on Running Intensity

    by Emily Balcetis, Jordan S. Daley, Corey Guenther, Matthew Riccio, Jason Kemp, Emmanuel Lapitan, Joshua Pesantes, Andrew Voigt, Yuanqi Gu, Shana Cole

    Does the shifting of visual attention serve as a self-regulatory strategy by people persist through effortful tasks to complete goals? Across six studies ( n = 1,590) focusing on running goals, runners increasingly narrowed and decreasingly widened attention over time as they neared a goal (Studies 1, 2, and 4). Suggesting its effectiveness, narrowing rather than widening attention increased effort investment; runners experimentally assigned to narrow rather than widen attentional scope (Studies 3A and 3B) at the beginning rather than the end (Study 3C) ran faster paces (Studies 3A, 3B, and 3C) and invested more effort as indexed by heart rate (Study 3B). Better runners, including elite competitive runners (Study 1) and faster runners as indexed by self-reported pace (Study 2) and competition performance times (Study 4) tended to rely on attentional narrowing. We discuss the implications of attentional scope shifting as a general regulatory control strategy.


  • Open Access

    Personalized and adaptive physical activity-based social comparison opportunities for women with health risks: Insights from a real-time test of the identification/contrast model

    by Danielle Arigo, Iris Bercovitz, Anisha Satish, Emmanuel Lapitan, Amanda L Folk, Andrea F Lobo

    Women in midlife (ages 40–60) experience unique risk for cardiovascular disease, in part due to insufficient physical activity (PA). Although social comparison can motivate PA, how best to harness this process is unclear. The Identification/Contrast Model proposes a useful framework but has not been tested in real time. We tested this model among 88 women (mean age = 51.6 years, mean BMI = 31.9 kg/m 2 ) who viewed comparison targets via personalized and adaptive peer profiles, once per day for 7 days. They also wore PA monitors, responded to profiles in real time, and completed subsequent qualitative interviews. Results from multilevel models support the Identification/Contrast Model for upward comparison, though responses to downward comparison were complex; narrative feedback highlighted the benefits of affiliative responses. Findings demonstrate within-person variability in comparison response that is often overlooked and support the utility of the Identification/Contrast Model for improving the use of comparison processes to promote PA.


  • Open Access

    Social Comparison and Mental Health

    by Danielle Arigo, Iris Bercovitz, Emmanuel Lapitan, Sofia Gular

    Purpose of Review: Opportunities for social comparison, or self-evaluation relative to others, are increasingly common via technologies such as mobile apps and social media. Comparison is often assumed to be detrimental for mental health, as many studies show negative associations. Yet, the majority of existing studies use weak methods that do little to inform clinical efforts. The goals of this review are to describe advances in methods for studying the impact of social comparisons on mental health and to identify critical next steps to advance treatment. Recent Findings: Methods such as intensive ambulatory assessment (e.g., ecological momentary assessment), creative approaches to experimental manipulation, and just-in-time adaptive interventions are increasingly popular and reveal the complexity of social comparison’s short- and longer-term effects. Findings highlight the need for personalized and context-sensitive approaches to promoting mental health. Summary: Historical assumptions about the role of social comparison in mental health outcomes are based on a preponderance of cross-sectional research that offers little to our understanding of mechanistic pathways or effective treatments. As the consequences of comparisons can be negative or positive, in the short and long terms, and can vary within person, there is a pressing need for treatment approaches that address this complexity in context.


  • Open Access

    Cancer Resource and Information Support (CRIS) for Bladder Cancer Survivors and Their Caregivers: Development and Usability Testing Study

    by Michael A Diefenbach, Allison Marziliano, Elizabeth J Siembida, Thomas Mistretta, Halie Pfister, Andrea Yacoub, Kelli Aibel, Priya Patel, Emmanuel Lapitan, Erin K Tagai, et al.

    Background: Bladder cancer survivors and their caregivers face profound practical (eg, use of stoma appliances and care for urinary diversion methods) and psychosocial (eg, depression and anxiety) challenges after surgical treatment with cystectomy. Objective: To improve the health-related quality of life and postsurgical outcomes of both bladder cancer survivors and their caregivers, the team, in collaboration with Sourcetop, Inc (software design) and Dappersmith (graphic design), developed the Cancer Resource and Information Support (CRIS) software. The purpose of this manuscript is to report on the development and usability testing of the CRIS software. Methods: The development of the CRIS software was guided by the Obesity-Related Behavioral Intervention Trials (ORBIT) model for developing behavioral treatments for chronic diseases. The ORBIT model is unique in that it proposes a flexible and progressive process with prespecific clinically significant milestones for forward movement and returns to earlier stages for refinement, and it facilitates communication among diverse groups by using terminology from the drug development model. This paper focuses on 2 phases of the ORBIT model: phase IA: define and IB: refine. During phase IA, the study team developed solutions for the stated clinical problem—adjustment to life post cystectomy—by reviewing the literature and collecting feedback from clinicians, professional organizations, bladder cancer survivors, and their caregivers. During Phase IB, the study team focused on tailoring content in the CRIS software to the user as well as usability testing with 7 participants. Results: The finished product is CRIS, a web-based software for survivors of bladder cancer and their caregivers to serve as a health management and lifestyle resource after surgery. Overarching themes from phase IA (participant feedback) included how to use new medical equipment, tips and tricks for easier living with new medical equipment, questions about health maintenance, and questions about lifestyle modifications. To accommodate our target population, we also incorporated recommendations from the Americans with Disabilities Act for website design, such as large text size, large paragraph spacing, highly contrasting text and background colors, use of headings and labels to describe the purpose of the content, portrait orientation without the need for horizontal scrolling, multiple ways to access a web page within a set of pages, ability to navigate web pages in sequential order, and in-text links that are descriptive. Usability participants evaluated CRIS very positively, indicating that it was easy to use, the functions were well-integrated, and if available, they would use CRIS frequently. Conclusions: CRIS, developed over the course of 18 months by integrating feedback from experts, literature reviews, and usability testing, is the first web-based software developed for bladder cancer survivors and their caregivers to help them adjust to life following cystectomy. The efficacy of CRIS in improving patients’ and caregivers’ quality of life is currently being evaluated in a randomized controlled trial.


  • Open Access

    Preference Elicitation and Treatment Decision-Making among Men Diagnosed with Prostate Cancer: Results from the Healium Trial (Preprint)

    by Michael Diefenbach, Allison Marziliano, Erin K. Tagai, Halie Pfister, Emmanuel Lapitan, Simon Hall, Manish Vira, Said Ibrahim, Kelli Aibel, Alexander Kutikov, et al.

    Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Elicitation of patients’ preferences is an integral part of shared decision making, the recommended approach for prostate cancer decision making. However, existing decision aids for this population do not specifically focus on patients’ preferences. Healium is a brief interactive web-based decision aid that aims to elicit patient’s treatment preferences and is designed for a low health literate population. Objective: This study used a randomized controlled trial to evaluate whether Healium (designed to target preference elicitation) is as efficacious as Healing Choices (a comprehensive education and decision tool) in improving outcomes for decision-making and emotional quality of life. Methods: Patients diagnosed with localized prostate cancer who had not yet made a treatment decision were randomly assigned to the brief Healium intervention or Healing Choices, an extensive decision aid previously developed by our group that serves as a virtual information center on prostate cancer diagnosis and treatment. Assessments were completed at baseline, 6-weeks and 3-months post-baseline, and included decisional outcomes (decisional conflict, satisfaction with decision, preparation for decision-making), and emotional quality of life (anxiety/tension and depression), along with demographics, comorbidities, and health literacy. Results: N = 327 individuals consented to participate in the study (171 were randomized to the Healium intervention arm and 156 were randomized to Healing Choices). The majority of the sample was non-Hispanic (96%), White (76%), married (78.4%), and had an average age of 62.4 years old (SD = 6.9). Within both arms, there was a significant decrease in decisional conflict from baseline to 6-weeks post baseline (Healium, P = <.001; Healing Choices, P = <.001), and a significant increase in satisfaction with one’s decision from 6 weeks to 3 months (Healium, P = .04; Healing Choices, P = .01). Within both arms, anxiety/tension (Healium, P = .23; Healing Choices, P = .27) and depression (Healium, P = .001; Healing Choices, P = <.001) decreased from baseline to 6-weeks, but only in the case of depression was the decrease statistically significant. Conclusions: Healium, our brief decision aid focusing on treatment preference elicitation, is as successful in reducing decisional conflict as our previously tested comprehensive decision aid, Healing Choices, and has the added benefit of brevity and the potential for integration into the physician consultation and electronic medical record. Clinical Trial: ClinicalTrials.gov NCT05800483; https://clinicaltrials.gov/ct2/show/NCT05800483


  • Open Access

    Preference Elicitation and Treatment Decision-Making Among Men Diagnosed With Prostate Cancer: Randomized Controlled Trial Results of Healium (Preprint)

    by Michael A Diefenbach, Allison Marziliano, Erin K Tagai, Halie Pfister, Emmanuel Lapitan, Simon J Hall, Manish Vira, Said Ibrahim, Kelli Aibel, Alexander Kutikov, et al.

    BACKGROUND Elicitation of patients’ preferences is an integral part of shared decision-making, the recommended approach for prostate cancer decision-making. Existing decision aids for this population often do not specifically focus on patients’ preferences. Healium is a brief interactive web-based decision aid that aims to elicit patients’ treatment preferences and is designed for a low health literate population. OBJECTIVE This study used a randomized controlled trial to evaluate whether Healium, designed to target preference elicitation, is as efficacious as Healing Choices, a comprehensive education and decision tool, in improving outcomes for decision-making and emotional quality of life. METHODS Patients diagnosed with localized prostate cancer who had not yet made a treatment decision were randomly assigned to the brief Healium intervention or Healing Choices, a decision aid previously developed by our group that serves as a virtual information center on prostate cancer diagnosis and treatment. Assessments were completed at baseline, 6 weeks, and 3 months post baseline, and included decisional outcomes (decisional conflict, satisfaction with decision, and preparation for decision-making), and emotional quality of life (anxiety/tension and depression), along with demographics, comorbidities, and health literacy. RESULTS A total of 327 individuals consented to participate in the study (171 were randomized to the Healium intervention arm and 156 were randomized to Healing Choices). The majority of the sample was non-Hispanic (272/282, 96%), White (239/314, 76%), married (251/320, 78.4%), and was on average 62.4 (SD 6.9) years old. Within both arms, there was a significant decrease in decisional conflict from baseline to 6 weeks postbaseline (Healium, P≤.001; Healing Choices, P≤.001), and a significant increase in satisfaction with one’s decision from 6 weeks to 3 months (Healium, P=.04; Healing Choices, P=.01). Within both arms, anxiety/tension (Healium, P=.23; Healing Choices, P=.27) and depression (Healium, P=.001; Healing Choices, P≤.001) decreased from baseline to 6 weeks, but only in the case of depression was the decrease statistically significant. CONCLUSIONS Healium, our brief decision aid focusing on treatment preference elicitation, is as successful in reducing decisional conflict as our previously tested comprehensive decision aid, Healing Choices, and has the added benefit of brevity, making it the ideal tool for integration into the physician consultation and electronic medical record. CLINICALTRIAL ClinicalTrials.gov NCT05800483; https://clinicaltrials.gov/study/NCT05800483

  • Open Access

    Cancer Resource and Information Support (CRIS) for Bladder Cancer Survivors and Their Caregivers: Development and Usability Testing Study (Preprint)

    by Michael A Diefenbach, Allison Marziliano, Elizabeth J Siembida, Thomas Mistretta, Halie Pfister, Andrea Yacoub, Kelli Aibel, Priya Patel, Emmanuel Lapitan, Erin K Tagai, et al.

    BACKGROUND Bladder cancer survivors and their caregivers face profound practical (eg, use of stoma appliances and care for urinary diversion methods) and psychosocial (eg, depression and anxiety) challenges after surgical treatment with cystectomy. OBJECTIVE To improve the health-related quality of life and postsurgical outcomes of both bladder cancer survivors and their caregivers, the team, in collaboration with Sourcetop, Inc (software design) and Dappersmith (graphic design), developed the Cancer Resource and Information Support (CRIS) software. The purpose of this manuscript is to report on the development and usability testing of the CRIS software. METHODS The development of the CRIS software was guided by the Obesity-Related Behavioral Intervention Trials (ORBIT) model for developing behavioral treatments for chronic diseases. The ORBIT model is unique in that it proposes a flexible and progressive process with prespecific clinically significant milestones for forward movement and returns to earlier stages for refinement, and it facilitates communication among diverse groups by using terminology from the drug development model. This paper focuses on 2 phases of the ORBIT model: phase IA: define and IB: refine. During phase IA, the study team developed solutions for the stated clinical problem—adjustment to life post cystectomy—by reviewing the literature and collecting feedback from clinicians, professional organizations, bladder cancer survivors, and their caregivers. During Phase IB, the study team focused on tailoring content in the CRIS software to the user as well as usability testing with 7 participants. RESULTS The finished product is CRIS, a web-based software for survivors of bladder cancer and their caregivers to serve as a health management and lifestyle resource after surgery. Overarching themes from phase IA (participant feedback) included how to use new medical equipment, tips and tricks for easier living with new medical equipment, questions about health maintenance, and questions about lifestyle modifications. To accommodate our target population, we also incorporated recommendations from the Americans with Disabilities Act for website design, such as large text size, large paragraph spacing, highly contrasting text and background colors, use of headings and labels to describe the purpose of the content, portrait orientation without the need for horizontal scrolling, multiple ways to access a web page within a set of pages, ability to navigate web pages in sequential order, and in-text links that are descriptive. Usability participants evaluated CRIS very positively, indicating that it was easy to use, the functions were well-integrated, and if available, they would use CRIS frequently. CONCLUSIONS CRIS, developed over the course of 18 months by integrating feedback from experts, literature reviews, and usability testing, is the first web-based software developed for bladder cancer survivors and their caregivers to help them adjust to life following cystectomy. The efficacy of CRIS in improving patients’ and caregivers’ quality of life is currently being evaluated in a randomized controlled trial.